IL6 and COVID-19: Our study suggests that for asymptomatic or mild COVID-19 patients with low IgG levels, using IL-6 blockers, receiving vaccinations, and/or treating comorbidities can enhance the immune response to SARS-CoV-2, thereby reducing the risk of long COVID and improving their quality of life.